
    
      PRIMARY OBJECTIVES:

      I. Assess the impact of cesium 131 (cesium Cs 131) on recurrence rate, disease free survival
      and over all survival.

      SECONDARY OBJECTIVES:

      I. Assess complications associated with cesium 131 treatment in subjects with head and neck
      cancer.

      OUTLINE:

      Patients undergo brachytherapy using cesium Cs 131 during surgical resection.

      After completion of study treatment, patients are followed up at 30 days and then every 3
      months for 24 months.
    
  